⌘K

Login Start Free

Home/Filings/4/0001415889-23-014406

4//SEC Filing

Galle Liz 4

Accession 0001415889-23-014406

CIK 0001235912other

View on SEC.gov Company Profile

Filed

Oct 17, 8:00 PM ET

Accepted

Oct 18, 4:51 PM ET

Size

6.7 KB

Accession

0001415889-23-014406

Insider Transaction Report

Form 4

Period: 2023-10-16

VP of Global Clinical Research

Transactions

Exercise/Conversion
Common Stock
2023-10-16$0.24/sh+778$184→ 778 total
Exercise/Conversion
Stock Option (right to buy)
2023-10-16−778→ 0 total
Exercise: $0.24Exp: 2023-11-11→ Common Stock (778 underlying)

Footnotes (1)

[F1]Fully vested.

Documents

1 file

4
form4-10182023_081024.xmlPrimary

Issuer

CVRx, Inc.

CIK 0001235912

Entity typeother

Related Parties

1

filerCIK 0001869353

Filing Metadata

Form type: 4
Filed: Oct 17, 8:00 PM ET
Accepted: Oct 18, 4:51 PM ET
Size: 6.7 KB

View on SEC.gov